The spleen of (PvG/c×DA)Fl rats, intravenously injected with carbon, was investigated. Large heavily carbon-laden (LHC) macrophages, which were found only in the red pulp at 30 min, appeared along marginal zone bridging channels (MZBC) from the red pulp towards the white pulp side successively during 1–6 h after carbon injection. After this time, they appeared in the periarterial lymphatic sheaths (PALS) near MZBC and then in the deeper PALS along the arteries by 5–10 days. Frequently, they were found in rows from MZBC into the white pulp. These findings suggest migration of LHC macrophages from the red towards the white pulp trough MZBC. Possible migration of LHC macrophages through MZBC was observed for a long period – at least 3 months examined. LHC macrophages came together preferentially in PALS and in and around the germinal centers consisting of large pyroninophilic lymphoblastoid cells. Occasionally, possible migration of LHC macrophages from regions around sinuses crossing the marginal zone vertically (vertical sinus) was also observed. Sinuses accompanied by LHC macrophages often ran parallel in close association with MZBC, particularly at sites of MZBC near the red pulp.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.